Who founded NKore Biotherapeutics?

NKore Biotherapeutics was founded by Anahid Jewett in 2020.

How much funding has NKore Biotherapeutics raised?

NKore Biotherapeutics has disclosed $250K raised across 1 round.

Where is NKore Biotherapeutics headquartered?

NKore Biotherapeutics is headquartered in Germantown, US.

NKore Biotherapeutics

Germantown, US · Founded 2020 · Delaware LLC

NKore BioTherapeutics is a cellular-based biotherapeutics company developing an allogeneic immunotherapy platform based on a proprietary method of activating natural killer (NK) cells, called Supercharged NK (sNK) cells. Its lead therapy, NK101, targets solid and blood cancers in adult and pediatric patients, with human clinical trials planned in the United States beginning in 2027.

Biotech Healthtech

Founders & leadership

NKore Biotherapeutics was founded in 2020 by Anahid Jewett.

Anahid JewettCo-founder & Chief Scientific Advisor

R Gregory BrophyExecutive

Tracy RyanExecutive

Board

Timothy BrahmBoard director

Diederik van der ReijtBoard director

Reported raises · per SEC filings

Form D private placements

$250K disclosed across 1 round · 2023

▶$250KraisedApr 2023 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

R Gregory BrophyExecutive Officer, Director
Tracy RyanExecutive Officer, Director
Timothy BrahmDirector
Diederik van der ReijtDirector

Offering amount: $3M
Amount sold: $250K
Minimum investment: $25K
Proceeds to insiders: $11.5K
First sale: Mar 2023
Incorporated: Limited Liability Company, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

MD Anderson Cancer Center34 shared keywordsUT MD Anderson is a cancer hospital providing cancer treatment, prevention, clinical care, and research, including new therapies and clinical trials for cancer patients. It is ranked among the top hospitals in the U.S. for cancer care.

Companies competing with NKore Biotherapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does NKore Biotherapeutics do?: NKore BioTherapeutics is a cellular-based biotherapeutics company developing an allogeneic immunotherapy platform based on a proprietary method of activating natural killer (NK) cells, called Supercharged NK (sNK) cells. Its lead therapy, NK101, targets solid and blood cancers in adult and pediatric patients, with human clinical trials planned in the United States beginning in 2027.
Who founded NKore Biotherapeutics?: NKore Biotherapeutics was founded by Anahid Jewett in 2020.
How much funding has NKore Biotherapeutics raised?: NKore Biotherapeutics has disclosed $250K raised across 1 round.
Where is NKore Biotherapeutics headquartered?: NKore Biotherapeutics is headquartered in Germantown, US.